Segall Bryant & Hamill »

Blueprint Medicines shares owned by Segall Bryant & Hamill

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Segall Bryant & Hamill from 13F filings

Historical chart of Segall Bryant & Hamill investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Segall Bryant & Hamill consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Segall Bryant & Hamill

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 142k 92.50
2024-06-30 $14M 127k 107.78
2024-03-31 $12M 124k 94.86
2023-12-31 $12M 125k 92.24
2023-09-30 $4.8M 95k 50.22
2023-06-30 $6.0M 96k 63.20
2023-03-31 $4.3M 95k 44.99
2022-12-31 $8.0M 183k 43.81
2022-09-30 $14M 209k 65.90
2022-06-30 $10M 204k 50.49
2022-03-31 $11M 175k 63.89
2021-12-31 $6.3M 59k 107.11
2021-09-30 $4.5M 43k 102.78
2021-06-30 $3.7M 42k 87.98
2021-03-31 $3.9M 40k 97.22
2020-12-31 $4.5M 40k 112.14
2020-09-30 $3.8M 41k 92.69
2020-06-30 $885k 11k 78.13
2020-03-31 $642k 11k 58.43
2019-12-31 $968k 12k 80.12